These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36966029)

  • 1. Blockade of CD122 on memory T cells in the skin suppresses sclerodermatous graft-versus-host disease.
    Kubota N; Tanaka R; Ichimura Y; Konishi R; Tso JY; Tsurushita N; Nomura T; Okiyama N
    J Dermatol Sci; 2023 Mar; 109(3):127-135. PubMed ID: 36966029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-Ī³-Stimulated Apoptotic Keratinocytes Promote Sclerodermatous Changes in Chronic Graft-Versus-Host Disease.
    Saito A; Ichimura Y; Kubota N; Tanaka R; Nakamura Y; Fujisawa Y; Watanabe R; Ishitsuka Y; Fujimoto M; Okiyama N
    J Invest Dermatol; 2021 Jun; 141(6):1473-1481.e4. PubMed ID: 33242500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human placental mesenchymal stromal cells promote the formation of CD8
    Zhao Y; Chen Z; Wu Y; Zhang J; Zhang H; Han K; Wang H; Li H; Luan X
    Int Immunopharmacol; 2024 Sep; 138():112554. PubMed ID: 38968861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.
    Okiyama N; Katz SI
    J Autoimmun; 2014 Sep; 53():1-9. PubMed ID: 25047812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cells (MSCs) AttenuateĀ Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model.
    Lim JY; Ryu DB; Lee SE; Park G; Min CK
    J Invest Dermatol; 2017 Sep; 137(9):1895-1904. PubMed ID: 28526296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.
    Villarroel VA; Okiyama N; Tsuji G; Linton JT; Katz SI
    J Invest Dermatol; 2014 Jun; 134(6):1552-1560. PubMed ID: 24390137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
    Huu DL; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    Arthritis Rheum; 2013 Jun; 65(6):1624-35. PubMed ID: 23508350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.
    Richmond JM; Strassner JP; Zapata L; Garg M; Riding RL; Refat MA; Fan X; Azzolino V; Tovar-Garza A; Tsurushita N; Pandya AG; Tso JY; Harris JE
    Sci Transl Med; 2018 Jul; 10(450):. PubMed ID: 30021889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases.
    Nozawa K; Ohata J; Sakurai J; Hashimoto H; Miyajima H; Yagita H; Okumura K; Azuma M
    J Immunol; 2001 Nov; 167(9):4981-6. PubMed ID: 11673505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
    Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
    J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development.
    Castro I; Yu A; Dee MJ; Malek TR
    J Immunol; 2011 Nov; 187(10):5170-82. PubMed ID: 21984699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice.
    Shibaki A; Sato A; Vogel JC; Miyagawa F; Katz SI
    J Invest Dermatol; 2004 Jul; 123(1):109-15. PubMed ID: 15191550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease.
    Miyagawa F; Tagaya Y; Kim BS; Patel HJ; Ishida K; Ohteki T; Waldmann TA; Katz SI
    J Immunol; 2008 Jul; 181(2):1109-19. PubMed ID: 18606663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis.
    Kim BS; Miyagawa F; Cho YH; Bennett CL; Clausen BE; Katz SI
    J Invest Dermatol; 2009 Dec; 129(12):2805-17. PubMed ID: 19554018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-15-dependent CD8+ CD122+ T cells ameliorate experimental autoimmune encephalomyelitis by modulating IL-17 production by CD4+ T cells.
    Yu P; Bamford RN; Waldmann TA
    Eur J Immunol; 2014 Nov; 44(11):3330-41. PubMed ID: 25142300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model.
    Lim JY; Ryu DB; Kim TW; Lee SE; Park G; Yoon HK; Min CK
    Stem Cell Res Ther; 2020 Jun; 11(1):254. PubMed ID: 32586381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-reactive CD8+ memory stem cells in graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    Nat Med; 2005 Dec; 11(12):1299-305. PubMed ID: 16288282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Xenogeneic Graft-Versus-Host Disease Model for Investigating the Pathological Role of Human CD4
    Ito R; Katano I; Kawai K; Yagoto M; Takahashi T; Ka Y; Ogura T; Takahashi R; Ito M
    Am J Transplant; 2017 May; 17(5):1216-1228. PubMed ID: 27862942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-18 prevents the development of chronic graft-versus-host disease in mice.
    Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M
    J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.